Published : 3 years ago, on 21/07/2021

High disease prevalence across the globe coupled with ongoing research and development is expected to stimulate market growth

According to the current analysis of Reports and Data, the global hematological cancers therapeutics market accounted for USD 31.32 Billion in 2018 and is expected to reach USD 66.34 billion by 2026 , at a CAGR of 9.8 percent. Hematology Cancer Therapeutics market is majorly driven by a high incidence of blood cancer across the globe and favorable funding scenario for the research and development of therapeutics for blood cancer. In terms of region, Asia Pacific is estimated to grow at a CAGR of 10.5 % followed by North America with 9.6% percent.

Additionally, the increase in pressure has driven the market of pharmaceutical companies into the launch of new drugs, considering the upcoming patent expiries of several drugs by 2026. In line with this, key market players focus on the launch of new hematological cancers therapeutics in the market. Owing to the strong presence of pharmaceutical companies and the high prevalence of blood cancer in the region, North America is expected to dominate the hematological cancers therapeutics market during the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1068

Further key findings from the report suggest

• The market for pharmacological therapies market is projected to grow significantly and deliver a CAGR of 10.5 percent. Owing to pressure for the development of new drugs in lieu of upcoming patent expiries of several drugs by 2026, the leading market players of Hematology Cancer Therapeutics market are focusing on obtaining successful clinical trials to launch new drugs in the market
• The market for hospitals is anticipated to dominate the market with the revenue of 47.6 billion by 2026. Growth in blood cancer therapeutics market for this segment is supported by reimbursement from government as well as private bodies across the globe.
• Asia-Pacific will witness a significant rise at a CAGR of 10.5% from 2018 to 2026 in light of favorable government inclination towards the research and development related to blood cancers. Additionally, government hospital spending and infrastructure development rate across the globe has increased by 7 % during the period 2016-2017, with the majority of the new additions being derived from the Asia Pacific region.
• Key participants include Roche, Celgene, Johnson & Johnson, Karyopharm Therapeutics, Siemens AG, Mindray Medical, Abbott Laboratories, Bio-Rad Laboratories, AbbVie, HemoCue AB, Sysmex, and Novartis.

For the purpose of this report, Reports and Data has segmented the global hematological cancers therapeutics market on the basis of type, end-user, and region:

• Type Outlook (Revenue, USD Million, 2016 – 2026)
  • Pharmacological Therapies
  • Stem Cell Transplantation
  • Surgery and Radiation Therapy
  • Anemia Treatment
  • Thrombosis Treatment
  • Neutropenia Treatment
  • Others
• End User Outlook (Revenue, USD Million, 2016 – 2026)
  • Hospitals
  • Clinical Laboratories
  • Academic and Research Institutes
  • Others
• Regional Outlook (Revenue, USD Million, 2016 – 2026)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • The Netherlands
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Middle East Asia
  • Latin America
    • Brazil

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1068

Key Questions Answered by the Report:

• What are the key growth driving and restraining factors of the Hematological Cancers Therapeutics market?
• What are key opportunities and growth prospects of the Hematological Cancers Therapeutics industry is expected to witness over the forecast period?
• Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
• Which region is expected to dominate the market growth over the forecast period?
• Which segments are expected to register lucrative growth over the forecast period?
• What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1068

Thank you for reading our report. Please connect with us to know more about the report or for requesting customization of the report. Our team will ensure the report is best suited to meet your requirements.

Explore Reports and Data’s Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Hemodialysis and Peritoneal Dialysis Market Size, Share & Analysis, By Product & Services Type (Hemodialysis, Consumables, Hemodialysis analyzer product, Bloodline, Hemodialysis Concentrates, Others), By Modality (Hemodialysis, Peritoneal Dialysis), By Water Treatment System Type (Hemodialysis, Peritoneal), By End-Use (In-Center Dialysis, Hospitals, Independent Dialysis Centers, Home Dialysis), Forecasts To 2027

Immunohematology Market Size, Share & Analysis, By Product (Immunohematology Analyzer), By Application (Pretransfusion Testing), By Disease (HIV, Hepatitis), By End-use (Hospitals, Blood Banks, Diagnostic Laboratories), Forecasts To 2026

Hemostasis And Tissue Sealing Agents Market Analysis, By Type (Topical Hemostats, Adhesives & Tissue sealants), By Material Type (collagen based), By Applications Type (Minimally Invasive Surgery), By End Use (Hospital, Ambulatory Surgical Centers, Home Care Settings), Forecasts To 2026

Fixed & Mobile C-arms Market Analysis, By Device Type (Fixed C-arms, Mobile C-arms, Full Size C-arms, Mini C-arms) By Application Type (Gastroenterology, Pain Management, Orthopedics & Trauma, Neurosurgery, Cardiovascular) By End Use, Forecasts To 2026

Pneumatic Nebulizers Market Analysis, By Product Type (Ultrasonic Nebulizers, Pneumatic Nebulizers, Mesh Nebulizers) By End Users (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care), Forecasts To 2026

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

Read Full Press Release: https://www.reportsanddata.com/press-release/global-hematological-cancers-therapeutics-market

The post Hematological Cancers Therapeutics Market To Reach $66.34 Billion By 2026 – Reports And Data first appeared on News Degree | Hub for Latest and Trending News from Around the Globe.